[PDF][PDF] Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

HS Friedman, MD Prados, PY Wen… - Journal of clinical …, 2009 - researchgate.net
HS Friedman, MD Prados, PY Wen, T Mikkelsen, D Schiff, LE Abrey, WKA Yung
Journal of clinical oncology, 2009researchgate.net
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Page 1
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Henry S.
Friedman, Michael D. Prados, Patrick Y. Wen, Tom Mikkelsen, David Schiff, Lauren E. Abrey,
WK Alfred Yung, Nina Paleologos, Martin K. Nicholas, Randy Jensen, James Vredenburgh,
Jane Huang, Maoxia Zheng, and Timothy Cloughesy From the Brain Tumor Center, Duke
University, Durham, NC; Department of Neurosurgery, University of California, San Francisco …
Purpose
We evaluated the efficacy of bevacizumab, alone and in combination with irinotecan, in patients with recurrent glioblastoma in a phase II, multicenter, open-label, noncomparative trial.
researchgate.net